Calpain-1 and Calpain-2 Promote Breast Cancer Metastasis.
Ontology highlight
ABSTRACT: In breast cancer, progression from localized stage I to distant metastatic stage IV disease is associated with a reduction of 5-year survival from nearly 100% to 23.2%. Expression of the calcium-activated protease isoforms calpain-1 and calpain-2 has been correlated with cell migration and invasion in vitro, metastatic potential in preclinical mouse models of cancer, and breast cancer prognosis in patients. It is unclear which of these two calpain isoforms is responsible for the apparent metastatic potential of cancer cells. Here, we demonstrate that while individual CRISPR-Cas9 knockouts of either CAPN1 or CAPN2 genes (encoding the catalytic subunits of calpain-1 and -2, respectively) reduce in vitro migration and marginally suppress in vivo metastasis, genetic disruption of
SUBMITTER: Harper D
PROVIDER: S-EPMC12427806 | biostudies-literature | 2025 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA